CANF
Price
$1.05
Change
+$0.01 (+0.96%)
Updated
Jun 30, 04:58 PM (EDT)
Capitalization
14.12M
OTLC
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
19.19M
56 days until earnings call
Interact to see
Advertisement

CANF vs OTLC

Header iconCANF vs OTLC Comparison
Open Charts CANF vs OTLCBanner chart's image
Can-Fite BioPharma
Price$1.05
Change+$0.01 (+0.96%)
Volume$1.36K
Capitalization14.12M
Oncotelic Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$13.71K
Capitalization19.19M
CANF vs OTLC Comparison Chart in %
Loading...
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CANF vs. OTLC commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CANF is a Buy and OTLC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (CANF: $1.04 vs. OTLC: $0.05)
Brand notoriety: CANF and OTLC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CANF: 93% vs. OTLC: 29%
Market capitalization -- CANF: $14.12M vs. OTLC: $18.1M
CANF [@Biotechnology] is valued at $14.12M. OTLC’s [@Biotechnology] market capitalization is $18.1M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CANF’s FA Score shows that 0 FA rating(s) are green whileOTLC’s FA Score has 0 green FA rating(s).

  • CANF’s FA Score: 0 green, 5 red.
  • OTLC’s FA Score: 0 green, 5 red.
According to our system of comparison, CANF is a better buy in the long-term than OTLC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CANF’s TA Score shows that 2 TA indicator(s) are bullish while OTLC’s TA Score has 2 bullish TA indicator(s).

  • CANF’s TA Score: 2 bullish, 4 bearish.
  • OTLC’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CANF is a better buy in the short-term than OTLC.

Price Growth

CANF (@Biotechnology) experienced а -1.42% price change this week, while OTLC (@Biotechnology) price change was +0.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Reported Earning Dates

OTLC is expected to report earnings on Aug 25, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OTLC($19.2M) has a higher market cap than CANF($14.1M). OTLC YTD gains are higher at: 34.286 vs. CANF (-36.000). CANF has more cash in the bank: 995K vs. OTLC (79.2K). CANF has less debt than OTLC: CANF (40K) vs OTLC (13.3M).
CANFOTLCCANF / OTLC
Capitalization14.1M19.2M73%
EBITDAN/A-3.84M-
Gain YTD-36.00034.286-105%
P/E RatioN/AN/A-
RevenueN/A0-
Total Cash995K79.2K1,256%
Total Debt40K13.3M0%
FUNDAMENTALS RATINGS
CANF vs OTLC: Fundamental Ratings
CANF
OTLC
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
8863
P/E GROWTH RATING
1..100
10095
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CANF's Valuation (36) in the Biotechnology industry is in the same range as OTLC (54) in the null industry. This means that CANF’s stock grew similarly to OTLC’s over the last 12 months.

CANF's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as OTLC (100) in the null industry. This means that CANF’s stock grew similarly to OTLC’s over the last 12 months.

OTLC's SMR Rating (97) in the null industry is in the same range as CANF (98) in the Biotechnology industry. This means that OTLC’s stock grew similarly to CANF’s over the last 12 months.

OTLC's Price Growth Rating (63) in the null industry is in the same range as CANF (88) in the Biotechnology industry. This means that OTLC’s stock grew similarly to CANF’s over the last 12 months.

OTLC's P/E Growth Rating (95) in the null industry is in the same range as CANF (100) in the Biotechnology industry. This means that OTLC’s stock grew similarly to CANF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CANFOTLC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
84%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 18 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CANF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OTLC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GRNWF0.070.01
+12.00%
Greenlane Renewables Inc.
IPXHY14.030.20
+1.45%
Inpex Corp.
FFMR66.00N/A
N/A
First Farmers Financial Corp
HPHTF11.46N/A
N/A
Hamamatsu Photonics
MCAP10.10N/A
N/A
MCAP Inc.

CANF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CANF has been loosely correlated with LGVN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CANF jumps, then LGVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CANF
1D Price
Change %
CANF100%
+0.97%
LGVN - CANF
38%
Loosely correlated
+1.54%
OABI - CANF
35%
Loosely correlated
+0.59%
GBIO - CANF
29%
Poorly correlated
-15.40%
RNA - CANF
27%
Poorly correlated
-2.68%
IPSC - CANF
26%
Poorly correlated
-5.74%
More

OTLC and

Correlation & Price change

A.I.dvisor tells us that OTLC and THAR have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OTLC and THAR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLC
1D Price
Change %
OTLC100%
+4.44%
THAR - OTLC
25%
Poorly correlated
+2.41%
DRUG - OTLC
20%
Poorly correlated
-6.09%
CANF - OTLC
20%
Poorly correlated
+0.97%
MMIRF - OTLC
15%
Poorly correlated
N/A
NDTP - OTLC
2%
Poorly correlated
N/A
More